IMI International Medical Innovations to Present at the American Stock Exchange Annual Online Healthcare & Biotech Investor Conf

IMI International Medical Innovations to Present at the American
Stock Exchange Annual Online Healthcare & Biotech Investor Conference 


TORONTO, June 21  /PRNewswire-FirstCall/ -- IMI International Medical
Innovations Inc. (Amex: IME; TSX: IMI), a world leader in predictive medicine,
today announced that it will be presenting at the American Stock Exchange
Annual Online Healthcare & Biotech Investor Conference on Tuesday, June 22,
2004 at 10 a.m. (ET).

The webcast may be accessed at http://www.vcall.com/CEPage.asp?ID=88403. The
presentation will also be archived at http://www.vcallconferences.com/ and at
http://www.imimedical.com/.

Minimum requirements to listen to broadcast: Windows Media Player software,
downloadable free from http://microsoft.com/windows/windowsmedia/EN/default.asp
and at least a 28.8Kbps connection to the Internet. If you experience problems
listening to the broadcast, please email .

About IMI

IMI is a world leader in predictive medicine, dedicated to developing rapid,
non-invasive tests for the early detection of life-threatening diseases. IMI's
cardiovascular products, which are branded as PREVU(x) Coronary Heart Disease
Predictor, will be marketed and distributed worldwide by McNeil Consumer
Healthcare (J&J). The company's cancer tests include ColorectAlert(TM),
LungAlert(TM) and a breast cancer test. IMI's head office is located in
Toronto, and its research and product development facility is at McMaster
University in Hamilton, Ontario. For additional information, please visit
http://www.imimedical.com/. 

DATASOURCE: IMI International Medical Innovations Inc.



CONTACT: Sarah Borg-Olivier, Director, Communications, IMI International

Medical Innovations Inc., T: [phone], 

Copyright